Cresset Asset Management, LLC Cel Sci Corp Transaction History

Cresset Asset Management, LLC

  • $17.6 Billion
  • Q1 2025

A detailed history of Cresset Asset Management, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 17,376 shares of CVM stock, worth $39,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,376
Previous 17,376 -0.0%
Holding current value
$39,791
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.11 - $1.85 $5,550 - $9,250
5,000 Added 40.4%
17,376 $20,000
Q2 2023

Aug 14, 2023
BUY
$2.11 - $2.83 $26,113 - $35,024
12,376 New
12,376 $29,000

Others Institutions Holding CVM

# of Institutions
65
Shares Held
7.55M
Call Options Held
73.8K
Put Options Held
106K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $99.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email